Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

September 24, 2026 Drug delivery / Pharma applications

Paul Janssen was born 100 years ago

Probably, the most creative and productive pharmaceutical chemist of all time, Dr. Paul Adriaan Jan Janssen, was born 100 years

Continue reading

September 21, 2026 CD as API / CD derivatives / Pharma applications

Virus-Mediated Self-Assembly of Functional Cyclodextrins for Antiviral Inhibition

The autors report on a virus-mediated supramolecular assembly as an adaptive inhibitor of viral infection. Building on cyclodextrin (CD) host-guest

Continue reading

September 15, 2026 Drug delivery / Pharma applications

HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms

This study developed a new vaginal hydrogel to treat genitourinary syndrome of menopause, aiming to improve drug retention and patient

Continue reading

September 14, 2026 CD as API / Pharma applications

Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis

Purpose: Although sugammadex may promote earlier postoperative mobilization and transiently affect coagulation parameters, its association with the risk of venous

Continue reading

September 11, 2026 CD derivatives / Non-pharma applications / Pharma applications

Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”

The Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition” will be published in the International Journal of Molecular Sciences

Continue reading

September 9, 2026 Drug delivery / Pharma applications / Uncategorized

Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer

Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential

Continue reading

September 8, 2026 Drug delivery / Pharma applications

REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition

A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,

Continue reading

September 7, 2026 CD as API / Pharma applications

Reducing Cholesterol with β-CDP: Insights for NPC and AD

Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are neurodegenerative disorders characterised by cognitive dysfunction and neurological impairment. In

Continue reading

September 3, 2026 Drug delivery

Fast-Dissolving HPβCD Nanofibers with a combination of 3 drugs: A New Solution for Pain Relief

Researchers from the United States 🇺🇸 developed fast-dissolving HPβCD nanofibers containing a three-drug combination of aspirin, paracetamol, and caffeine commonly

Continue reading

a person wearing latex gloves using a microscope
September 2, 2026 CD derivatives / Diagnosis / Life sciences

Cyclodextrin Helps Analyzing 3D Histology of Archived Human Tissues

What if decades-old human tissue archives could be transformed from thin, two-dimensional histological sections into detailed three-dimensional maps of cells,

Continue reading

Posts pagination

1 2 3 … 132 Next Posts»

Recent Posts

  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Paul Janssen was born 100 years ago
  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
  • A cyclodextrin polymer that could change the future of batteries
  • Virus-Mediated Self-Assembly of Functional Cyclodextrins for Antiviral Inhibition

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (74)
  • CD as API (357)
  • CD derivatives (434)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (818)
  • E-ducation (63)
  • Environmental (144)
  • Events (241)
  • Food (234)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (417)
  • Other industrial use (113)
  • Pharma applications (1,223)
  • Supramolecular systems (44)
  • Uncategorized (168)

Top Posts

  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • BCD in starch-based composite active sheets for the preservation and packaging of blueberry fresh fruit
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Reinforced double-threaded slide-ring networks for accelerated hydrogel discovery and 3D printing
  • Cyclodextrin scientist ranked among the Best Chemistry Scientists of the World
  • Wasabi's bioactive component 6-MSITC formulated with alfa-cyclodextrin improved memory proven in clinical trial.
  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
  • Paul Janssen was born 100 years ago
  • Cothreading of Unmodified and Monoazidated β-Mixed cyclodextrins in polyrotaxanes for Niemann Pick disease
  • Alpha-cyclodextrin increases glucagon-like peptide-1 secretion in multiple models and improves metabolic status in mice

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,458 other subscribers
Loading Comments...